Press release
Bulbospinal Muscular Atrophy Drugs Market to See Strong Growth| Leadiant Biosciences, Inc, Abbott, Novo Nordisk A/S, Novartis AG, F. Hoffmann-La Roche Ltd
Bulbospinal Muscular Atrophy Drugs Market
Global bulbospinal muscular atrophy drugs market is growing at a steady CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the granting of various drug designations to novel drugs by the U.S FDA, initiatives undertaken by various public, as well as nonprofit, organizations for creating awareness regarding bulbospinal muscular atrophy and increase in R&D investment by major companies.
Request For Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bulbospinal-muscular-atrophy-drugs-market
The key market players in the global bulbospinal muscular atrophy drugs market are Novartis AG, F. Hoffmann-La Roche Ltd, Boehringer Ingelheim International GmbH, Pfizer Inc, Ionis Pharmaceuticals, Inc, CYTOKINETICS, INC, Regeneron Pharmaceuticals, Inc, Salarius Pharmaceuticals, Inc, Leadiant Biosciences, Inc, Abbott, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, AstraZeneca, Catalyst Pharma, PTC Therapeutics, Natera, Inc among others.
Market Definition:
Bulbospinal muscular atrophy is also known as Kennedy’s disease, a rare adult-onset form of spinal muscular atrophy (SMA) is an X-linked autosomal recessive progressive neurodegenerative disorder that causes weakening and wasting of the proximal and bulbar muscles. The condition occurs due to loss of nerve cells in the brain stem and spinal cord, this result in stoppage of messages from brain to muscles for movement. Patients with bulbospinal muscular atrophy have difficulty in speaking, standing, walking and controlling their head movements. In worse condition patients can have trouble swallowing and breathing. This disorder mainly affects men and does not occur in females, who are protected by their low levels of testosterone in the body, accounting for the sex-limited inheritance pattern of this disorder.
According to National Organization for Rare Disorders, Bulbospinal muscular atrophy or Kennedy disease is a very rare type of disorder and it affects 1 in 350,000 males and rarely seen in females. The Japanese population has a very high prevalence of this disorder because of a founder effect.
Market Drivers
Growing number of incidences of spinal bulbar muscular atrophy is driving the growth of the market
Initiatives undertaken by various public, as well as nonprofit, organizations for creating awareness regarding bulbospinal muscular atrophy also acts as a market driver
Increase in R&D investment by major companies is boosting the market growth
Increasing healthcare expenditure can also enhance the market growth
Market Restraints
High cost of treatment for bulbospinal muscular atrophy is hindering the market growth
Lack of experienced professionals in this field can also act as a restricting factor for the growth of this market
Limited number of drugs available for bulbospinal muscular atrophy treatment also hampers the market growth
For More Details In-Depth Inquiry @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-bulbospinal-muscular-atrophy-drugs-market
Segmentation:
By Drugs Class
5α-Reductase Inhibitors (5-ARIs)
Gonadotropin-releasing Hormone (GnRH) Agonists
Others
By Drugs
Leuprorelin
Dutasteride
Others
By Therapy
Physical Therapy
Occupational Therapy
Speech Therapy
By Treatment
Medication
Supportive Care
Surgery
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By End-Users
Hospitals
Homecare
Specialty Clinics
By Geography
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Key Developments in the Market
In April 2019, Novartis AG is developing BVS857, a novel drug for the treatment of bulbospinal muscular atrophy, currently ongoing in phase ll clinical trial. If approved this novel drug will provide a potential treatment for patients with bulbospinal muscular atrophy and help in improving their life
In August 2018, Takeda Pharmaceutical Company Limited is developing Leuprorelin, a gonadotropin-releasing hormone (GnRH) agonist for the treatment of bulbospinal muscular atrophy. If approved this drug will provide a potential treatment for patients with bulbospinal muscular atrophy
Table of Contents:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
1. Company Landscape
2. Company Profiles
3. Related Reports
Access Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-bulbospinal-muscular-atrophy-drugs-market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bulbospinal Muscular Atrophy Drugs Market to See Strong Growth| Leadiant Biosciences, Inc, Abbott, Novo Nordisk A/S, Novartis AG, F. Hoffmann-La Roche Ltd here
News-ID: 1862288 • Views: …
More Releases from Data Bridge Market Research
Ophthalmic Ultrasound Imaging Systems Market Size, Share, Trends, Key Drivers, G …
Global Ophthalmic Ultrasound Imaging Systems Market' the new research report adds in Data Bridge Market Research's reports database. This Research Report spread across 329 Page, 53 No of Tables, And 244 No of Figures with summarizing Top companies, with tables and figures. The Ophthalmic Ultrasound Imaging Systems market research report presents a comprehensive study on production capacity, consumption, import and export for all the major regions across the world. By…
Smartphone Sanitizer Market Size, Share, Trends, Key Drivers, Growth and Opportu …
Smartphone Sanitizer Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. The market research and analysis conducted in this report assists clients in forecasting the investment in an emerging market, growth of market share or success of a new product. In addition, this business report endows with a delegate overview of the market where it identifies industry trends, determines brand awareness, potency and insights…
Chemical Dust Suppressants Market Size, Share, Trends, Key Drivers, Growth and O …
Chemical Dust Suppressants Market research report has been prepared with the systematic gathering and evaluation of market information for industry which is presented in a form that explains various facts and figures to the business. Report saves valuable time as well as adds credibility to the work that is performed to grow business. This quality report has been planned with full commitment and transparency in research and analysis. With…
Farm Video Surveillance System Market Size, Share, Trends, Demand, Growth and Co …
Global Farm Video Surveillance System Market study by Data Bridge Market Research provides details about the market dynamics affecting the Farm Video Surveillance System market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. Farm Video Surveillance System market analysis report is the high quality report having in-depth market research studies.
For dominating the market or industry…
More Releases for Pharma
Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors.
Access the PDF sample of the report@…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period.
For More Info, Get Sample Report…
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide…
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry.
Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986
Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications…
